Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Athenex Inc ATNXQ

Healthcare Biotechnology
Athenex, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of next-generation products for the treatment of cancer. The Company's segments include Oncology Innovation Platform and Commercial Platform. The Oncology Innovation Platform is engaged in research and development of its drugs. The Commercial Platform is... see more

Recent & Breaking News (GREY:ATNXQ)

Athenex, Texas Children's Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine Present New Clinical Data on GD2 CAR-NKT Cells in Neuroblastoma at ASGCT Annual Meeting

GlobeNewswire May 17, 2021

Athenex Provides First Quarter 2021 Corporate and Financial Update

GlobeNewswire May 6, 2021

Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform

GlobeNewswire May 4, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX

Newsfile May 3, 2021

SHAREHOLDER DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA May 3, 2021

ATNX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Athenex, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: May 3, 2021

ACCESSWIRE IA May 3, 2021

DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile May 3, 2021

SHAREHOLDER ACTION ALERT: Labaton Sucharow Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. (NASDAQ: ATNX) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA May 3, 2021

DEADLINE ALERT for VLDR, REGI, OTRK, and ATNX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire May 3, 2021

MAY 3, 2021 ATNX INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Athenex, Inc.

PR Newswire May 3, 2021

ATNX DEADLINE TODAY: HAGENS BERMAN, National Trial Attorneys, Alerts Athenex (ATNX) Investors to Lead Plaintiff Dead in Securities Class Action, Advises Investors with Losses to Contact the Firm Immediately

ACCESSWIRE IA May 3, 2021

MAY 3 DEADLINE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA May 3, 2021

ATNX Final Deadline Tomorrow: Rosen, A Longstanding Law Firm, Encourages Athenex, Inc. Investors with Losses over $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action - ATNX

Newsfile May 2, 2021

FINAL DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA May 2, 2021

ATNX DEADLINE ALERT: HAGENS BERMAN, National Trial Attorneys, Alerts Athenex (ATNX) Investors to Monday May 3rd Application Deadline in Securities Class Action, Advises Investors with Losses to Contact the Firm Immediately

Newsfile May 2, 2021

ATNX DEADLINE MONDAY: HAGENS BERMAN, National Trial Attorneys, Alerts Athenex (ATNX) Investors to May 3rd Application Deadline in Securities Class Action, Advises Investors with Losses to Contact the Firm Immediately

GlobeNewswire May 1, 2021

FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Athenex, Inc. Investors With Losses over $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action - ATNX

GlobeNewswire May 1, 2021

FINAL DEADLINE MONDAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA May 1, 2021

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX

Newsfile April 30, 2021

SHAREHOLDER ACTION ALERT: Labaton Sucharow Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. (NASDAQ: ATNX) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 30, 2021